Page 2 - Tanmay Tiwary

Emkay sees ENBD deal transforming RBL Bank; retains 'Buy,' raises target

RBL Bank's management indicated that regulatory approvals for the deal are expected by mid-Q4FY26

Indraprastha Gas jumps 6% as Nomura upgrades stock on easing gas prices

On the bourses, IGL share price rallied up to 5.54 per cent to an intraday high of ₹193.35 per share, while MGL share price rose up to 4.22 per cent to an intraday high of ₹1,159.25.

JM Financial retains 'Buy' on Eternal as Blinkit growth moderates in Q3FY26

According to JM Financial, Blinkit's net order value (NOV) growth is likely to slow to around 13 per cent Q-o-Q in Q3FY26, compared with 25 per cent and 27 per cent growth in Q1 & Q2, respectively.

Nuvama upgrades Tata Power to 'Hold' on improved FY30 growth visibility

The brokerage's view followed an analyst meet held at Tata Power's Odisha Technology Centre, where management reiterated its long-term growth roadmap.

Hotels to see strong H2 as new airport, events boost demand: Motilal Oswal

The structural outlook remains favourable, analysts said. Mumbai contributes nearly 15 per cent to India's hotel room revenue and disproportionately dominates the luxury segment.

Analysts see big boom in battery storage; RIL, Waaree among key gainers

With 100GWh, 20GWh and 12GWh of planned capacities respectively, these players are set to benefit from what Nuvama calls an imminent J-curve demand breakout, reaffirming its 'Buy' rating on the theme.

India Inc faces capital allocation deadlock as demand softens, says Nuvama

In its third annual capital allocation study, Nuvama argued that a rare combination of slowing demand cycles and elevated valuations has left corporate India "all dressed up, but with nowhere to go."

Motilal Oswal initiates IKS, Sagility with 'Buy'; Indegene 'Neutral'

The US remains the world's most lucrative outsourcing market, with healthcare spending touching nearly $5 trillion in CY24, accounting for 17-18 per cent of GDP.

Sharekhan upgrades Divi's Labs to 'Buy' on strong FY26-28 growth visibility

The brokerage said Divis Laboratories is entering a stronger growth phase, supported by a robust H2FY26 pipeline and visibility for scale-up over the next two years.

Muted FY26 to fuel strong FY27 sales, profit rebound for India Inc: CLSA

After two strong years followed by a prolonged stretch of mid-single-digit revenue growth, India Inc. may be on the cusp of a more robust earnings cycle, analysts said.

Emirates NBD infusion to lift RBL Bank's growth prospects: Motilal Oswal

RBL Bank's C/I ratio remains elevated at 70.7 per cent due to investments in retail, digital and risk infrastructure, and lower treasury income in Q2FY26.

Nuvama starts with 'Buy' on Yatharth Hospitals amid strong growth outlook

Despite healthy performance, Yatharth still operates below industry benchmarks in terms of ARPOB and occupancy, offering major upside potential.

DBS flags 3 top risks to global markets in 2026; US tech correction looms

According to DBS, the first risk is a sharp correction in US equities, particularly in tech stocks linked to the AI investment wave.

Defence, aerospace to drive Bharat Forge; CV outlook unclear: Motilal Oswal

At the core of the bullish narrative is BHFC's swelling defence order book, now at nearly ₹114,000 crore and executable over the next three to four years.

Analysts see up to 54% upside in Coforge; Nomura calls it top midcap IT bet

Nomura, which termed Coforge its "top pick in the mid-cap India IT services sector," said the company is banking on a solution-led sales strategy to maintain its growth trajectory.

Nuvama upgrades Suzlon to 'Buy' as wind outlook improves, capacity ramps up

Suzlon Energy stock: The brokerage has trimmed its target price to ₹60 from ₹66, reflecting a lower valuation multiple due to a temporary slowdown in central tendering activity.

Nifty India Defence index down 2%; what's dragging defence stocks today?

Market experts attributed the weakness to a combination of valuation concerns, liquidity pressures and profit booking.

Diesel relief, LPG boost: Motilal Oswal pegs 31% upside for HPCL stock

Despite the near-term volatility, HPCL's valuations remain reasonable, the brokerage noted. The stock trades at 1.4x one-year forward price-to-book, slightly above its long-term average of 1.2x.

Gold loans, fee income to power Capri Global; JM Financial starts coverage

JM Financial said the non-bank lender's diversified retail-focused franchise, strong asset quality and expanding non-interest income engine position it well for sustained growth.

Aequs IPO opens December 3; should you bid? Check GMP, price band here

Aequs IPO to open on December 3, 2025: Aequs plans to use the IPO proceeds for a mix of debt reduction and business expansion.